Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupFrancesco Rodeghiero, James N. George|Blood|2008Cited by 2.6k
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J. Kuter, Janet L. Nichol, Alan Lichtin et al.|The Lancet|2008Cited by 862
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITPJames B. Bussel, Janet L. Nichol, David J. Kuter et al.|New England Journal of Medicine|2006Cited by 530
Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.James N. George, Peter J. Newman|Journal of Clinical Investigation|1986Cited by 448
Improved quality of life for romiplostim‐treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo‐controlled trialsJames N. George, Martin R. Schipperus, Susan D. Mathias et al.|British Journal of Haematology|2008Cited by 146